The largest database of trusted experimental protocols

Genejammer

Manufactured by Agilent Technologies
Sourced in United Kingdom, United States

The GeneJammer is a laboratory instrument designed for molecular biology applications. It functions as a versatile transfection reagent, enabling the introduction of genetic material, such as DNA or RNA, into cells for various research purposes. The product provides a convenient and efficient method for transfection, allowing researchers to study gene expression, knockdown, or other molecular-level processes in a controlled laboratory setting.

Automatically generated - may contain errors

30 protocols using genejammer

1

Engineered Bispecific IgG for Enhanced PcrV and Psl Targeting

Check if the same lab product or an alternative is used in the 5 most similar protocols
The sequences of the single specificity anti-PcrV IgG (clone V2L2MD) and engineered bispecific IgG (dual specificity for PcrV and Psl, clone MEDI3902) were obtained as previously described17 (link), 18 (link). The nucleotide sequence for each human IgG1 heavy and Igκ light chains were codon optimized for both mouse and human biases to enhance expression in mammalian cells39 (link), 40 (link). Sequences were also RNA optimized for improved mRNA stability. This has been shown to result in more efficient translation on the ribosome41 (link), 42 (link), leading to increase protein yield43 (link). The optimized heavy and light chain genes were then inserted into the pGX0001 DNA expression vector, under the control of a human cytomegalovirus promoter and bovine growth hormone polyA.
Both genes were encoded in cis, separated by a furin cleavage site (RGRKRRS) and P2A peptide. The result was two plasmids: DMAb-αPcrV and DMAb-BiSPA. HEK 293T cells were transfected with DMAb DNA using GeneJammer (Agilent, Wilmington, DE) transfection reagent. Cell supernatants and cell lysates were harvested 48 h post transfection and assayed for human IgG production by ELISA and Western blot.
+ Open protocol
+ Expand
2

HeLa Cell Transfection and FLIM Imaging

Check if the same lab product or an alternative is used in the 5 most similar protocols
HeLa cells were seeded with cell density of ∼120 000 cells per dish (35 mm sterile MatTek, glass bottom) in DMEM (Gibco) supplemented with 10% FBS (Gibco) and 2 mM final concentration of l-glutamine (Gibco). Cells were transfected with 1 μg of plasmid, or 1 μg each in case of co-transfections, using GeneJammer (Agilent) at a reagent:plasmid ratio of 3:1. At 48 h post transfection, medium was exchanged for DMEM (Gibco) supplemented with 10% FBS (Gibco) and 2 mM final concentration of l-glutamine (Gibco) and cells dishes were taken for FLIM measurements.
+ Open protocol
+ Expand
3

Endometrial Cancer Cell Transfection Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
AN3 CA cells (Manassas, VA, ATCC number: HTB-111), a human endometrial metastatic
cancer cell line that does not express endogenous gravin, and HEC 1A cells (ATCC HTB-112)
were maintained at 37°C with 5% CO2 in low glucose
Dulbecco’s Modified Eagle Medium (DMEM) supplemented with 10% fetal bovine
serum and 100 units/ml penicillin and 100ug/ml streptomycin. Growth medium was replaced
three times each week and cells were split 1:25 upon reaching confluence.
Cells were plated at 25,000 cells per cm2 onto glass coverslips in a
6-well plate (9.6 cm2 per well). Upon 70% confluence (2–3
days), cells were transfected for an additional 24 hours in a solution containing
3μl/ml GeneJammer (Agilent) and 1μg/ml total plasmid DNA. For experiments
involving co-transfection with AKAR3 and gravin constructs, it was critical that cells
expressing AKAR3 were also expressing gravin. A 1:3 molar ratio of AKAR3:gravin plasmid
DNA in the transfection mixture yielded transfected cultures in which roughly 90%
of cells expressing AKAR3 were also positive for gravin expression (See Fig. 1F).
+ Open protocol
+ Expand
4

Adenovirus-Based Fluorescent Reporters

Check if the same lab product or an alternative is used in the 5 most similar protocols
Laconic8 (link), ATeam, or FLIIPglu700 containing plasmid (Addgene: 44238, 51958, and 17866 respectively) were cloned into Ad5 adenovirus by VectorLabs for construction of Adenovirus-Laconic (Ad-Lac), Adenovirus-ATeam (ad-ATeam), or adenovirus-FLIIPglu700 (ad-Glu). Ad-LifeAct-RFP (ad-LifeAct) was from Ibidi (60122). For transduction into endothelial cells, Ad-Lac at 50:1 multiplicity of infection (MOI), ad-ATeam at 100:1 MOI, and ad-Glu at 200:1 MOI in 1:1 EGM2 media:Opti-MEM (ThermoFisher, 11058021) and 3 μL GeneJammer (Agilent, 204130) per milliliter of final volume was added for 1 hour before replacement of media. For migration and contraction experiments, ad-Lac and ad-LifeAct were co-transduced each with MOI 50:1. Endothelial cells were used 48 hours post transduction to allow for cell recovery and maximal fluorescence.
+ Open protocol
+ Expand
5

Quantitative Analysis of Transfected Protein

Check if the same lab product or an alternative is used in the 5 most similar protocols
One day prior to transfection, 293 T cells were plated at a density of 0.5 × 106 cells in a 6-well plate and transfected with 1 μg plasmid DNA using Gene Jammer (Agilent Technologies). Forty-eight hours post transfection, culture supernatants were collected, and cells were lysed using cell lysis buffer (Cell Signaling) containing protease inhibitor cocktail (Cell Signaling). Approximately 50 μg of culture supernatants and cell lysates were run with an Odyssey Protein Molecular weight ladder (Licor) on 4–12% pre-cast bis-tris gel (Invitrogen). The separated peptides were transferred to PVDF membrane (iblot 2, Thermo Fisher). The membrane was blocked with Odyssey blocking buffer (Licor) for 1 h at room temperature. Heavy and light chains were detected using IRDye 680RD goat anti-human IgG (H + L) (Licor). The blot was scanned using Odyssey CLx (Licor).
+ Open protocol
+ Expand
6

SARS-CoV-2 Pseudovirus Neutralization Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
SARS-CoV-2 pseudovirus was produced using HEK293T cells transfected with a 1:1 ratio of IgE-SARS-CoV-2 S plasmid (Genscript) and pNL4-3.Luc.R-E plasmid (NIH AIDS reagent) using Gene Jammer (Agilent) as transfection reagent. Forty-eight hours post transfection, transfection supernatant was collected, enriched with fetal bovine serum (FBS) to 12% final volume, and stored at −80°C. SARS-Cov-2 pseudovirus neutralization assay was set up using D10 medium (DMEM supplemented with 10% FBS and 1× penicillin-streptomycin) in a 96-well format using huCHOAce2 cells (Creative Biolabs, catalog no. VCeL-Wyb019). For neutralization assay, 10,000 CHO-ACE2 cells were plated in 96-well plates and rested overnight at 37°C and 5% CO2 for 24 h. CTB-ACE2 cells at specific weights were incubated with a fixed amount of SARS-Cov-2 pseudovirus for 90 min at room temperature in complete medium. After centrifugation at 15,005 rpm for 10 min, the supernatant of this mix was added to huCHOAce2 cells and allowed to incubate in a standard incubator (37% humidity, 5% CO2) for 72 h. After 72 h, cells were lysed using the Britelite Plus luminescence reporter gene assay system (PerkinElmer, catalog no. 6066769), and relative light units were measured using a BioTek plate reader. Percent neutralization was calculated using GraphPad Prism 8.
+ Open protocol
+ Expand
7

Transfection Optimization with Genejammer and FuGENE

Check if the same lab product or an alternative is used in the 5 most similar protocols
Transfections were performed using Genejammer (Agilent Technologies, Cheshire, UK) or FuGENE (Promega, Southampton, UK) transfection reagents according to the manufacturer's instructions or the calcium phosphate precipitation procedure modified by the use of {N,N-bis(2-hydroxyetyhl)-2-aminoethanesulfonic acid}-buffered saline (pH 7.06) as previously described (Batchelor and O'Hare, 1992 (link)). Routinely, 0.5–1 μg of the appropriate expression vector was transfected with amounts of DNA normalized using pUC19 carrier DNA.
+ Open protocol
+ Expand
8

Plasmid DNA Transfection in hPSCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Plasmid DNA, CSII-EF-EGFP, was constructed from CSII-EF-RfA, which was a kind gift from Dr. Hiroyuki Miyoshi (RIKEN BioResource Center, Tsukuba, Japan). TALEN plasmid DNA driven by the human elongation factor 1-alpha 1 (EF1α) promoter was constructed as described previously24 (link) with some modifications. Briefly, DNA-binding modules were assembled with the two-step Golden Gate assembly method using the Platinum Gate TALEN Kit (Addgene). The CMV promoter of ptCMV-136/63-VR vector was replaced with the EF1α promoter. Dissociated hPSCs were seeded at a density of 1.2 × 105/well in MATRIX-coated 12-well plates and cultured for 24 h. Both 1 μg of plasmid DNA and 4 μL of FuGENE HD (Promega) were diluted in 100 μL of Opti-MEM I Reduced Serum Media (Life Technologies) and incubated for 15 min at room temperature. This mixture was transferred to one well of a 12-well plate. Twenty-four hours post-transfection, cells were analyzed for enhanced green fluorescent protein (eGFP) expression to determine transfection efficiency. GeneJammer (Agilent Technologies), X-tremeGENE HP (Roche), and Lipofectamine 2000 (Invitrogen) were used following the manufacturers' instructions. Transfected cells were observed under a fluorescence microscope (BZ-9000; Keyence) and analyzed using BZ-Analyzer software (Keyence).
+ Open protocol
+ Expand
9

HEK293T Cell Transfection for DMAb Production

Check if the same lab product or an alternative is used in the 5 most similar protocols
At 1 day prior to transfection, HEK293T cells were plated at 0.25 × 106 cells/well in a 12-well tissue culture-treated plate. Cells were transfected with 0.5 μg/DMAb-plasmid using GeneJammer (Agilent Technologies), and cell supernatants were harvested 40 h later. Human IgG DMAb concentration was quantified by ELISA.
+ Open protocol
+ Expand
10

Msi1 Overexpression in 293T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
293T cells were transfected using GeneJammer (Agilent Technologies) with either a pcDNA3.1 plasmid (Life Technologies) containing Msi1 coding sequence or GST coding sequence (negative control). Cells were harvested for western analysis, using protocols described bellow, 72 hours post-transfection.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!